• Google: Behind the Curtain

    Oct 17, 2012, 10:00 AM by Michael Croft
    Wired | A peek into Google's top secret data center featuring a Google Street View tour and more.
    Full story

  • Biotech IPOs: More to be Expected?

    Oct 17, 2012, 09:00 AM by Michael Croft
    Forbes | Are Biotech IPOs back? Two recent offerings netted 20% above their offer price.
    Full story

  • Appistry to License Broad's GATK 2.0 to For Profit Users

    Oct 16, 2012, 07:00 AM by Michael Croft
    Bio-IT World | The Broad Institute and Appistry announced an arrangement this morning for Appistry to distribute and support the Broad’s Genome Analysis Toolkit (GATK) for next-generation sequencing data analysis. For a subscription fee, Appistry will distribute the GATK and its suite of analysis tools to for-profit users and provide commercial-grade customer support. 
    Full story

  • New Cancer Center Planned for Northern Virginia

    Oct 15, 2012, 14:00 PM by Michael Croft
    Washington Business Journal | A new comprehensive cancer center planned for Northern Virginia might be able to accomplish what Dietrich Stephan's Ignite Institue wasn't able to.
    Full story

  • News from Vienna: BT, Aspera, GenoLogics, CLC

    Oct 15, 2012, 08:00 AM by Michael Croft
    Bio-IT World | Bio-IT World Europe wrapped up in Vienna last week. A full report will follow, but first, some company announcement highlights from BT, Aspera, GenoLogics, CLC bio.
    Full story

  • AstraZeneca Inks Chinese Drug Discovery Partnership

    Oct 15, 2012, 08:00 AM by Michael Croft
    Bloomberg | AstraZeneca has partnered with Beijing-based Pharmaron to expand their R&D efforts. The partnership adds "a few hundred" researchers to AstraZeneca's team in China.
    Full story

  • Whole Genome Class for Medical Students

    Oct 12, 2012, 14:00 PM by Michael Croft
    Nature News Blog | Mount Sinai Medical School in New York is offering an elective course called ‘Practical Analysis of Your Personal Genome’ this year. The goal is to teach upcoming physicians how sequencing information might affect clinical care.
    Full story

  • IMPROVER-ing Data Verification for Systems Biology

    Oct 12, 2012, 09:00 AM by Michael Croft
    Bio-IT World | There was CASP. Then there was DREAM. And now, IMPROVER. The latest algorithm competition is tackling data verification in systems biology research. 
    Full story

  • GSK Releases 200 TB Compounds for Open Innovation

    Oct 11, 2012, 10:00 AM by Michael Croft
    PM Live | GlaxoSmithKline has released access to 200 compounds with possible action against tuberculosis in a move toward an "open innovation" approach to R&D.
    Full story

  • FDA Recalls Generic that Doesn't Work

    Oct 11, 2012, 09:00 AM by Michael Croft
    Forbes | The FDA took a generic version of Wellbutrin XL off the market yesterday because it just doesn't work--and hasn't worked for years.
    Full story

  • True Blood: Swiss Start-Up Biognosys Pushes Personalized Proteomics

    Oct 10, 2012, 12:00 PM by Michael Croft
    Bio-IT World | As biotech catchphrases go, “personalized proteomics” hasn’t quite registered as much as some, but according to Swiss biotech company Biognosys, recent advances in mass spectrometry and bioinformatics could have enormous ramifications for biomedical research, drug discovery, and even consumer health.
    Full story

  • Nobel Prize in Chemistry Awarded for Receptor Work

    Oct 10, 2012, 09:00 AM by Michael Croft
    Bio-IT World Roundup | The Nobel Prize in chemistry was awarded to two doctors for their work with G-protein-coupled receptors.
    Full story

  • The Intersection of Genetics and Economics

    Oct 10, 2012, 08:00 AM by Michael Croft
    Nature News | A paper slated to appear in the American Economic Review claims that a country's genetic diversity can predict the success of its economy. Critics worry that the paper is making claims that the inverse is also true.
    Full story

  • Science Prizes as Awards or Incentives

    Oct 9, 2012, 11:00 AM by Michael Croft
    The Guardian | With the announcement of the Nobel Prize in physics, The Guardian looks at the pros and cons of scientific awards as rewards or as incentives.
    Full story

  • The Prosecution RESTs

    Oct 8, 2012, 09:00 AM by Michael Croft
    Bio-IT World | Inside the Box Guest Column | Life Technologies has recently delivered version 3.0 of the Torrent Suite software, which includes updates to the RESTful API. Finally, in an industry chronically plagued with data integrity problems, a simple, modern API is available. 
    Full story

  • Health IT Company Claims 47 Second Genome Analysis

    Oct 8, 2012, 08:00 AM by Michael Croft
    eWeek | Health IT company NantHealth has introduced a supercomputing platform that it says can reduce the time required to analyze genomic data of a cancer patient from eight weeks to 47 seconds.
    Full story

  • University Medical Center Invests $100 Million in IT from IBM, Oracle

    Oct 8, 2012, 07:00 AM by Michael Croft
    eWeek | The University of Pittsburgh Medical Center has announced a five-year, $100 million investment in data warehousing and analytic tools incorporating IT infrastructure from dbMotion, IBM, Informatica, and Oracle.
    Full story

  • Grad Programs Launch for Data Wrangling

    Oct 8, 2012, 05:00 AM by Michael Croft
    Computerworld | Graduate schools are recognizing the need for big-data degrees, and several have launched Master's programs in science or business analytics designed to train students to manage and process massive datasets.
    Full story

  • TGEN Focuses on Childhood Rare Disorders

    Oct 5, 2012, 15:00 PM by Michael Croft
    AZ Central | The Translational Genomics Research Institute is launching the TGen Center for Rare Childhood Disorders to use sequencing technology to identify rare diseases.
    Full story

  • Large Genome Study to Delineate Breast Cancers

    Oct 5, 2012, 08:05 AM by Michael Croft
    Singularity HUB | A collaborative study investigated the genomes 825 breast cancer patients at different stages of disease.
    Full story